AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indaptus Therapeutics, Inc. Director's Dealing 2021

Aug 6, 2021

35475_dirs_2021-08-06_2e99a25f-ba2f-4f0b-831d-ab4e777cc718.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Indaptus Therapeutics, Inc. (INDP)
CIK: 0001857044
Period of Report: 2021-08-03

Reporting Person: Newman Michael James (Director, Chief Scientific Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1388356	Indirect

Footnotes

F1: Consists of (i) 1,361,524 shares of common stock held by the Michael J. Newman Trust, dated January 21, 2008, Michael J. Newman, Trustee, and (ii) 26,832 shares of common stock held by his spouse Janet Lee Harris, Trustee of the Janet Harris Living Trust, executed on March 25, 2009.